Management Change/Compensation Form 8 K

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On September 19, 2024, the Compensation Committee (the "Committee") of the Board of Directors (the "Board") of The Beachbody Company, Inc. (the "Company") amended the stock option previously granted to Mr. Goldston under the Company's 2023 Employment Inducement Incentive Award Plan in June 2023 (the "Option").

The Option covers an aggregate of 477,661 shares of the Company's Class A common stock, after taking into account the 1-for-50 reverse stock split that we effectuated in November 2023. Of this amount, 159,221 shares subject to the Option were scheduled to vest based on continued service and 318,440 shares were scheduled to vest based on the attainment of applicable performance goals and continued service. As amended by the Committee, the Option no longer will be subject to performance goals and instead will be scheduled to vest solely based on continued service, such that all 477,661 shares subject to the Option will vest and become exercisable as to 25% of the shares on each of the first four anniversaries of June 15, 2023, subject to Mr. Goldston's continued service through the applicable vesting date (the "Amendment").

The foregoing description of the Amendment does not purport to be complete and is subject to and qualified in its entirety by reference to the Amended and Restated Stock Option Inducement Grant Notice and Agreement, a copy of which will be filed as an exhibit to the Company's Annual Report on Form 10-K for the year ending December 31, 2024.

The Board approved the repricing of the exercise price of outstanding underwater stock options previously granted to certain eligible employees and other service providers (including certain of our named executive officers), including the Option. Effective as of November 13, 2024, these options will have an exercise price per share equal to $6.43, which was the closing price of our common stock on that date. Options held by our Chief Executive Officer and any member of the Board (other than Mr. Goldston) were not eligible to participate in the repricing.